Cell surface heparan sulfate and its roles in assisting viral infections

Medicinal Research Reviews

Volumn 22, Issue 1, 2002, Pages 1-25

  Liu, Jian ^a   Thorp, Suzanne C ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Heparan sulfate; Heparan sulfate proteoglycans and viral infections; Heparin

Indexed keywords

ANTIVIRUS AGENT; HEPARAN SULFATE;

CELL SURFACE; INFECTION RISK; NONHUMAN; PROTEIN BINDING; REVIEW; TARGET CELL; VIRUS CELL INTERACTION; VIRUS INFECTION;

CARBOHYDRATE CONFORMATION; CARBOHYDRATE SEQUENCE; CELL MEMBRANE; HEPARITIN SULFATE; HUMANS; MOLECULAR SEQUENCE DATA; VIRUS DISEASES;

EID: 0036139068     PISSN: 01986325     EISSN: None     Source Type: Journal    
DOI: 10.1002/med.1026     Document Type: Review

References (139)

1. Current evidence and future directions for targeting HIV entry
2. Microbial adherence to and invasion through proteoglycans
3. Glycosaminoglycan-binding microbial proteins in tissue adhesion and invasion: Key events in microbial pathogenicity
4. Cell surface receptors for herpes simplex virus are heparan sulfate proteoglycans
5. A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus I entry
6. Internalization of HIV-1 Tat requires cell surface heparan sulfate proteoglycans
7. Efficient infection of cells in culture by type O foot-mouth disease virus requires binding to cell surface heparan sulfate
8. Three classes of cell surface receptors for alphaherpesvirus entry
9. Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate
10. The fusion domain of HIV gp 41 interacts specifically with heparan sulfate on the T-lymphocyte cell surface
11. Differences in the susceptibility of herpes simplex virus types 1 and 2 to modified heparin compounds suggest serotype differences in viral entry
12. Structural requirement of heparan sulfate for interaction with herpes simplex virus type 1 virons and isolated glycoprotein C
13. Regulated diversity of heparan sulfate
14. Heparan sulfate heterogeneity in skeletal muscle basal lamina: Demonstration by phage display-derived antibodies
15. Syndecans, heparan sulfate proteoglycans, maintain the proteolytic balance of acute wound fluids
16. Perlecan is essential for cartilage and cephalic development
17. Dally cooperates with drosophila frizzled 2 to transduce wingless signalling
18. The cell-surface proteoglycan dally regulates wingless signaling in Drosophila
19. The EXT2 multiple exostoses gene defines a family of putative tumour suppressor genes
20. The putitive tumour suppressor EXT1 alters the expression of cell-surface heparan sulfate
21. Renal agenesis in mice homozygous for a gene trap mutation in the gene encoding heparan sulfate 2-sulfotransferase
22. Syndecan-1 is required for Wnt-1-induced mammary tumorigenesis in mice
23. Heparan sulfate proteoglycans of the cardiovascular system: Specific structures emerge but how is synthesis regulated?
24. Specificities of heparan sulfate proteoglcans in developmental processes
25. Functions of cell surface heparan sulfate proteoglycans
26. The elusive functions of proteoglycans: In vivo veritas
27. Molecular cloning of a phosphatidylinositol-anchored membrane heparan sulfate proteoglycan from human lung fibroblasts
28. Molecular cloning of syndecan, an integral membrane proteoglycan
29. Members of the syndecan family of heparan sulfate proteoglycans are expressed in distinct cell-, tissue-, and development-specific patterns
30. Biology of the syndecans: A family of transmembrane heparan sulfate proteoglycans
31. Shedding of syndecan-1 and -4 ectodomains is regulated by multiple signaling pathways and mediated by a TIMP-3-sensitive metalloproteinase
32. Syndecan-1 shedding is enhanced by LasA, a secreted virulence factor of Pseudomonas aeruginosa
33. Exploitation of syndecan-1 shedding by Pseudomonas aeruginosa enhances virulence
34. Cell surface heparan sulfate proteoglycans: Selective regulators of ligand-receptor encounters
35. Syndecan 4 heparan sulfate proteoglycan is a selectively enriched and widespread focal adhesion component
36. Heparan sulfate chains from glypican and syndecans bind the Hep II domain of fibronectin similarly despite minor structural differences
37. Characterization of the high affinity cell-binding domain in the cell surface proteoglycan syndecan-4
38. Tyrosine phosphorylation of syndecan-1 and -4 cytoplasmic domains in adher B82 fibroblasts
39. The role of syndecan cytoplasmic domain in basic fibroblast growth factor-dependent signal transduction
40. Regulation of syndecan-4 phosphorylation in vivo
41. Mechanisms underlying preferential assembly of heparan sulfate on glypican-1
42. Proteoglycans in the developing brain: New conceptual insights for old proteins
43. Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome
44. Mutational analysis of the GPC3/GPC4 glypican gene cluster on Xq26 in patients with Simpson-Golabi-Behmel syndrome: Identification of loss-of-function mutations in the GPC3 gene
45. Glycosaminoglycan-protein interactions: Definition of consensus sites in glycosaminoglycan binding proteins
46. Structural differences and the presence of unsubstituted amino groups in heparan sulfates from different tissues and species
47. Structure of heparan sulphate from human brain, with special regard to Alzheimer's disease
48. Contribution of monosaccharide residues in heparin binding to antithrombin HI
49. Minimal sequence in heparin/heparan sulfate required for binding of basic fibroblast growth factor
50. Requirement for anticoagulant heparan sulfate in the fibroblast growth factor receptor complex
51. Synthesis of thrombin-inhibiting heparin mimetics without side effects
52. Utility of non-covalent complex in the matrix-assisted laser desorption ionization mass spectrometry of heparin-derived oligosaccharides
53. Sequencing complex polysaccharides
54. Analysis of heparan sulfate oligosaccharides by nanoelectrospray ionization mass spectrometry
55. Evidence for a 3-O-sulfated D-glucosamine residue in the antithrombin-binding sequence of heparin
56. The interaction of heparin with thrombin and antithrombin
57. The disaccharide composition of heparins and heparan sulfates
58. Electrophoresis for the analysis of acidic oligosaccharides
59. Pathway-specific regulation of the biosynthesis of anticoagulantly active heparan sulfate
60. Expression of heparan sulfate D-glucosaminyl 3-O-sulfotransferase isoforms reveals novel substrate specificities
61. Substrate specificity of the heparin lyases from Flavobacterium heparinum
62. Cell surface syndecan-1 on distinct cell types differs in fine structure and ligand binding of its heparan sulfate chains
63. Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis
64. Structural studies on the bacterial lyase-resistant tetrasaccharides derived from the antithrombin III-binding site of porcine intestinal heparin
65. Heparan sulfate D-glucosaminyl 3-O-sulfotransferase-3A sulfates N-unsubstituted glucosamine residues
66. Formation of anhydrosugars in the chemical depolymerization of heparin
67. Characterization of a cell mutant specifically defective in the synthesis of anticoagulantly active heparan sulfate
68. Microanalysis of glycosaminoglycan-derived oligosaccharides labeled with a fluorophore 2-aminobenzamide by high-performance liquid chromatography: Application to disaccharide composition analysis and exosequencing of oligosaccharides
69. Strategy for the sequence analysis of heparin
70. Highly sensitive sequencing of the sulfated domains of heparan sulfate
71. A strategy for rapid sequencing of heparan sulfate and heparin saccharides
72. Sequencing of 3-0 sulfate containing heparin decasaccharides with a partial antithrombin HI binding site
73. Mass spectrometric and capillary electrophoretic investigation of the enzymatic degradation of heparin-like glycosaminoglycans
74. Molecular modeling of protein-glycosaminoglycan interactions
75. Heparin structure and interactions with basic fibroblast growth factor
76. Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization
77. Implications for function and therapy of a 2.9 Å structure of binary-complexed antithrombin
78. The tumor suppressor EXT-like gene EXTL2 encodes an α1,4-N-acetylhexosaminyltransferase that transfers N-acetylgalatosamine and N-acetylglucosamine to the common glycosaminoglycan-protein linkage region
79. The putative tumor suppressors EXT1 and EXT2 are glycosyltransferases required for the biosynthesis of heparan sulfate
80. Molecular cloning and expression of rat liver N-heparan sulfate sulfotransferase
81. Biosynthesis of heparin/heparan sulfate. cDNA cloning and expression of D-glucuronyl C5-epimerase from bovine lung
82. Molecular cloning and expression of Chinese hamster ovary cell heparan-sulfate 2-sulfotransferase
83. Molecular cloning and expression of mouse and human cDNAs encoding heparan sulfate D-glucosaminyl 3-O-sulfotransferase
84. Diversity of the extensive heparan sulfate D-glucosaminyl 3-O-sulfotransferase (3-OST) multigene family
85. The occurrence of three isoforms of heparan sulfate 6-O-sulfotransferase having different specificities for hexuronic acid adjacent to the targeted N-sulfoglucosamine
86. Multiple isozymes of heparan sulfates/heparin GIcNAc N-deacetylase/GlcN N-sulfotransferase: Structure and activity of the fourth member, NDST4
87. Purification of heparan sulfate D-glucosaminyl 3-O-sulfotransferase
88. Anticoagulant heparan sulfate precursor structures in F9 embryonic carcinoma cells
89. Infections with herpes simplex viruses
90. Initial interaction of herpes simplex virus with cells is binding to heparan sulfate
91. Glycoprotein gIII deletion mutants of pseudorabies virus are impaired in virus entry
92. Glycoprotein C of herpes simplex virus type 1 plays a principal role in the adsorption of virus to cells and in infectivity
93. Localization of a functional site on herpes simplex virus type 1 glycoprotein C involved in binding to cell surface heparan sulfate
94. Herpes simplex virus virus infection and propagation in a mouse L cell mutant lacking heparan sulfate proteoglycans
95. Differences in the role of glycoprotein C of HSV-1 and HSV-2 in viral binding may contribute to serotype differences in cell tropism
96. Evidence for an interaction of herpes simplex virus with chondroitin sulfate proteoglycans during infection
97. Swine testis cells contain functional heparan sulfate but are defective in entry of herpes simplex virus
98. Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family
99. Entry of alphaherpesviruses mediated by poliovirus receptor-related protein 1 and poliovirus receptor
100. A cell surface protein with herpesvirus entry activity (HveB) confers susceptibility to infection by mutants of herpes simplex virus type 1, herpes simplex virus type 2, and pseudorabies virus
101. Herpes simplex virus glycoprotein D can bind to poliovirus receptor-related protein A or herpes entry mediator, two structurally unrelated mediators of virus entry
102. The murine homolog (MpH) of human herpesvirus entry protein B (HveB) mediates entry of pseudorabies virus but not herpes simplex virus types 1 and 2
103. Striking similarity of murine nectin-1α to human nectin-1α (HveC) in sequence and activity as a gD receptor for alphaherpesvirus entry
104. The murine homolog of human nectin 1δ serves as a species nonspecific mediator for entry of human and animal alphaherpesviruses in a pathway independent of a detectable binding to gD
105. Comparison of murine and human nectin 1 binding to herpes simplex virus glycoprotein D (gD) reveals a weak interaction of murine nectin 1 to gD and a gD-dependent pathway of entry
106. HIV-1 attachment: Another look
107. Mediation of human immunodeficiency virus type 1 binding by interaction of cell surface heparan sulfate proteoglycans with the V3 region of envelope gp120-gp41
108. Role of cell surface glycosaminoglycans of human T cells in human immunodeficiency virus type-1 (HIV-1) infection
109. Tat as a transcriptional activator and a potential therapeutic target for HIV-1
110. Multiple interactions of HIV-I Tat protein with size-defined heparin oligosaccharides
111. AAV vectors: Is clinical success on the horizon?
112. Biology of adeno-associated virus
113. Membrane-associated heparan sulfate proteoglycan is a receptor for adenoassociated virus type 2 virions
114. The use of adenoassociated virus to circumvent the maturation-dependent viral transduction of muscle fibers
115. αVβ5 integrin: A co-receptor for adeno-associated virus type 2 infection
116. Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2
117. The interaction of heparan sulfate and adeno-associated virus 2
118. The scientific challenge of hepatitis C
119. Suramin blocks hepatitis C binding to human hepatoma cells in vitro
120. A model for the hepatitis C virus envelope glycoprotein E2
121. Heparan sulfate proteoglycans initiate dengue virus infection of hepatocytes
122. CD48 binds to eparan sulfate on the surface of epithelial cells
123. Initiation of human cytomegalovirus infection requires initial interaction with cell surface heparan sulfate
124. A27L protein mediates vaccinia virus interaction with cell surface heparan sulfate
125. Human papillomavirus infection requires cell surface heparan sulfate
126. The fusion glycoprotein of human respiratory syncytial virus facilitates virus attachment and infectivity via an interaction with cellular heparan sulfate
127. Heparin-like structures on respiratory syncytial virus are involved in its infectivity in vitro
128. The varicella zoster virus glycoprotein B (gB) plays a role in virus binding to cell surface heparan sulfate proteoglycans
129. Entry and egress of varicella-zoster virus: Role of mannose 6-phosphate, heparan sulfate proteoglycan, and signal sequences in targeting virions and viral glycoproteins
130. The furin protease cleavage recognition sequence of sindbis virus PE2 can mediate virion attachment to cell surface heparan sulfate
131. Binding of sindbis virus to cell surface heparan sulfate
132. The structure and function of a foot-and-mouth disease virus-oligosaccharide receptor complex
133. Interaction between pseudorabies virus and heparin/heparan sulfate. Pseudorabies virus mutants differ in their interaction with heparin/heparan sulfate when altered for specific glycoprotein C heparin-binding domain
134. Bovine herpesvirus 1 glycoprotein B does not productively interact with cell surface heparan sulfate in a pseudorabies virion background
135. Passage of classical swine fever virus in cultured swine kidney cells selects virus variants that bind to heparan sulfate due to a single amino acid change in envelope protein E (ms)
136. Heparan sulfate glycosaminoglycans are involved in adenovirus type 5 and 2-host cell interactions